Search

Your search keyword '"Hogervorst, Frans B L"' showing total 406 results

Search Constraints

Start Over You searched for: Author "Hogervorst, Frans B L" Remove constraint Author: "Hogervorst, Frans B L"
406 results on '"Hogervorst, Frans B L"'

Search Results

1. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

3. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

4. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation.

5. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

6. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

8. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation

9. Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

11. A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants : Application to BRCA1 and BRCA2

12. Two truncating variants in FANCC and breast cancer risk

13. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

14. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

16. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

17. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

20. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

21. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

22. Additional file 1 of Breast cancer risks associated with missense variants in breast cancer susceptibility genes

25. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

26. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

28. No evidence that GATA3 rs570613 SNP modifies breast cancer risk

30. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

33. Additional file 1 of BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

34. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants

35. MUTYH and the mismatch repair system: partners in crime?

36. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

37. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

38. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

39. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

40. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

41. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

44. Presence of ATM Protein and Residual Kinase Activity Correlates with the Phenotype in Ataxia-Telangiectasia: A Genotype–Phenotype Study†

45. ENIGMA—Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

47. Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐ BRCA1 /2 sib trios affected with breast cancer

49. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

50. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Catalog

Books, media, physical & digital resources